Purchases and Sales Made in Q1 2023 in Sc Pharmaceuticals Inc. (SCPH)
This table provides information about the institutional ownership of Sc Pharmaceuticals Inc. (SCPH) during Q1 2023. The information is specifically focused on institutions that hold shares of scPharmaceuticals Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-60.3K- 53.52% |
$337K - $571K
|
52.4K
$170K
|
|
|
May 15, 2023
Q1 2023
|
J. Goldman & CO LP
New York, NY |
SELL
|
- |
-110K- 61.88% |
$613K - $1.04M
|
67.5K
$219K
|
|
|
May 15, 2023
Q1 2023
|
Worth Venture Partners, LLC
Fort Lee, NJ |
SELL
|
- |
-117K- 18.6% |
$652K - $1.11M
|
511K
$1.66M
|
|
|
May 15, 2023
Q1 2023
|
Aigh Capital Management LLC
Baltimore, MD |
SELL
|
- |
-474K- 18.6% |
$2.65M - $4.49M
|
2.08M
$6.75M
|
|
|
May 15, 2023
Q1 2023
|
5 Am Venture Management, LLC
San Francisco, CA |
SELL
|
- |
-1.53M- 56.1% |
$8.58M - $14.5M
|
1.2M
$3.9M
|
|
|
Jul 12, 2023
Q1 2023
|
Eam Investors, LLC
Solana Beach, CA |
SELL
|
- |
-6.51M- 97.46% |
$36.4M - $61.6M
|
169K
$550K
|